Related Experiment Video
Updated: Apr 18, 2026
11:17
Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical Illnesses
Published on: August 30, 2018
13.6K
Rapid-onset piperacillin-tazobactam induced thrombocytopenia
Shamsuddin Shaik1, Haseeb A Kazi2, Peter T Ender3
1Department of Internal Medicine, St Luke's University Hospital, Bethlehem, PA, USA.
Journal of Pharmacy Practice
|January 23, 2015
Summary
Rapid-onset thrombocytopenia can occur with piperacillin/tazobactam, a common antibiotic. This rare side effect developed quickly in two patients, differing from typical prolonged-use reactions.
Area of Science:
- Pharmacology
- Hematology
- Clinical Medicine
Background:
- Drug-induced thrombocytopenia is a known adverse effect of beta-lactam antibiotics.
- Typically, this reaction is associated with prolonged antibiotic use.
- Piperacillin/tazobactam is a widely prescribed broad-spectrum antibiotic.
Observation:
- Two patients presented with rapid-onset thrombocytopenia.
- The thrombocytopenia occurred shortly after administration of piperacillin/tazobactam.
- Alternative causes for immediate thrombocytopenia were ruled out.
Findings:
- This case series highlights a rare presentation of rapid-onset thrombocytopenia.
- The adverse event was linked to piperacillin/tazobactam.
- The rapid onset contrasts with the more common delayed reactions.
Implications:
- Clinicians should be aware of the potential for rapid-onset thrombocytopenia with piperacillin/tazobactam.
- Early recognition and discontinuation may be crucial for patient management.
- Further investigation into the mechanisms of acute piperacillin/tazobactam-induced thrombocytopenia is warranted.
Related Concept Videos
01:20Desensitization and Tachyphylaxis
3.5K
Tachyphylaxis is described as a rapid decrease in response to a drug after repeated or continuous administration of the same drug dose. It is a phenomenon where the body becomes less responsive to a particular substance or intervention over time, requiring higher doses or stronger interventions to achieve the same effect. It results from adaptive changes in the body's receptors, signaling pathways, or physiological processes that occur in response to prolonged exposure to a stimulus.
3.5K
01:30Drug Toxicity: Allergic Reactions
181
Drug-related allergies are immune-mediated responses triggered by the administration of pharmacological agents. These hypersensitivity reactions are classified based on the immune mechanisms involved. The four primary types—Type I, II, III, and IV—are mediated by different immunological pathways and exhibit distinct clinical manifestations.Type I Hypersensitivity/ IgE-Mediated Reactions: Immunoglobulin E (IgE) immediately mediates Type I hypersensitivity reactions. Upon initial...
181
01:28Acute Pyelonephritis II: Diagnostic Studies and Management
750
Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...
750
01:24Drug Accumulation During Multiple Dosing: Intermittent IV Infusions
398
Intermittent intravenous (IV) infusion is a method of drug administration where medications are delivered over short infusion periods followed by intervals of no drug delivery. This approach helps to prevent sustained high drug concentrations in the bloodstream, reducing the risk of adverse effects associated with prolonged exposure. Unlike continuous infusion, steady-state concentrations may not be achieved during a single dosing cycle but can be reached through repeated...
398